✦ LIBER ✦
Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non–Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial
✍ Scribed by Cesare Gridelli; Jaafar Bennouna; Javier de Castro; Anne-Marie C. Dingemans; Frank Griesinger; Francesco Grossi; Antonio Rossi; Nick Thatcher; Elaine K. Wong; Corey Langer
- Book ID
- 113544760
- Publisher
- CIG Media Group, LP.
- Year
- 2011
- Tongue
- English
- Weight
- 268 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1525-7304
No coin nor oath required. For personal study only.